1
Clinical Trials associated with LGT (TP21)/DEN4(NIAID)Phase 1 Study of the Safety and Immunogenicity of Tick-Borne Langat/Dengue 4 Chimera (LGT(TP21)/DEN4), a Live Attenuated Vaccine for Tick-Borne Encephalitis
Tick-borne encephalitis (TBE) is a viral illness common in the Northern Hemisphere, especially Europe and Asia. TBE infection may lead to central nervous system problems and death. The purpose of this study is to test the safety of and immune response to a TBE vaccine in healthy adults. The vaccine is related to a live attenuated virus developed against dengue virus infection.
100 Clinical Results associated with LGT (TP21)/DEN4(NIAID)
100 Translational Medicine associated with LGT (TP21)/DEN4(NIAID)
100 Patents (Medical) associated with LGT (TP21)/DEN4(NIAID)
100 Deals associated with LGT (TP21)/DEN4(NIAID)